The HIV RNA levels of plasma and ocular fluids in AIDS patients with ophthalmic infections

Ophthalmologica

Volumn 218, Issue 5, 2004, Pages 328-332

  Hsu, Wen Ming ^a,d   Chiou, Shih Hwa ^a,c,e   Chen, Steve S L ^b   Shyong, Mon Ping ^a,d   Ho, Chi Kung ^a   Chen, Shih Jen ^a   Wu, Chih Chiau ^a   Kung, Szu Hao ^a   Chi, Chin Wen ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c Taoyuan Veterans Hospital   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Highly active antiretroviral therapy; Ophthalmic infections; Reverse transcriptase polymerase chain reaction

Indexed keywords

CD4 ANTIGEN; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AQUEOUS HUMOR; ARTICLE; BLOOD LEVEL; CELL COUNT; CHORIORETINITIS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPTOCOCCUS; CYTOMEGALOVIRUS; EYE DISEASE; EYE INFECTION; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MONITORING; OPPORTUNISTIC INFECTION; PATIENT; RANK SUM TEST; RETINITIS; RETINOPATHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOXOPLASMA; VIRUS LOAD;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; AQUEOUS HUMOR; CD4 LYMPHOCYTE COUNT; CHORIORETINITIS; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS RETINITIS; EYE INFECTIONS; HIV-1; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TOXOPLASMOSIS, OCULAR; VIRAL LOAD;

EID: 4444324755     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079475     Document Type: Article

References (18)

1. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG: Ocular manifestations of acquired immune deficiency syndrome. Ophthalmology 1989;96:1092-1099.
2. Kempen JH, Jabs DA, Wilson LA, Dunn JP, West SK: Risk of vision loss in patients with CMV retinitis and the acquired immunodeficiency syndrome. Arch Ophthalmol 2003;121;466-476.
3. Jacobson MA, Zegans M, Pavan PR, et al: Cytomegalovirus retinitis after initiation of highly active antiviral therapy. Lancet 1997;349:1443-1445.
4. Chiou SH, Liu CY, Hsu WM, Chan YJ, Chou CK, Chung YM, Liu JH, Liu WT, Chen SC, Wong WW: Ophthalmic findings in patients with acquired immunodeficiency syndrome. J Microbiol Immunol Infect 2000;33:45-48.
5. Chiou SH, Liu JH, Hsu WM, Chen SS, Chang SY, Wong WW, Liu CY, Liu WT, CW Wu: Upregulation of Fas ligand expression by human cytomegalovirus immediate-early gene 2: A novel mechanism in CMV-induced apoptosis in human retina. J Immunol 2001;167:4098-4103.
6. Bruno R, Sacchi P, Filice G: Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: Impact of highly active antiviral therapy. AIDS 2003;17:S83-S87.
7. Centers for Disease Control: Revision of the CDC surveillance case definition for AIDS. MMWR 1988;36(suppl 1S):1S-15S.
8. Cantrill HL, Henry K, Jackson B, Erice A, Ussery FM, Balfour HH Jr: Recovery of human immunodeficiency virus from ocular tissues in patients with acquired immune deficiency syndrome. Ophthalmology 1988;95:1458-1462.
9. Fujikawa LS, Salahuddin SZ, Ablashi D, Palestine AG, Nussenblatt RB, Gallo RC: HTLV-III in the tears of AIDS patients. Ophthalmology 1986;93:1479-1481.
10. Qavi HB, Green MT, Segall GK, Hollinger FB, Lewis DE: The incidence of HIV-1 and HHV-6 in corneal button. Curr Eye Res 1991;10:97-103.
11. Qavi HB, Green MT, Lewis DE, Hollinger FB, Pearson G, Ablashi DV: HIV-1 and HHV-6 antigens and transcripts in retinas of patients with AIDS in the absence of human cytomegalovirus. Invest Ophthalmol Vis Sci 1995;36:2040-2047.
12. Glasgow BJ: Evidence for breaches of the retinal vasculature in acquired immune deficiency syndrome angiopathy. Ophthalmology 1997; 104:753-760.
13. Gonzalez CR, Wiley CA, Arevalo JF, Garcia RF, Freeman WR: Polymerase chain reaction detection of cytomegalovirus and human immunodeficiency virus 1 in the retina of patients with acquired immune deficiency syndrome with and without cotton-wool spots. Retina 1996;16:305-311.
14. Capobianchi MR, Barresi C, Borghi P, Gessani S, Ameglio F, Belardelli F, Papadia S, Dianzani F: Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: Possible role of endogenous interleukin-8. J Virol 1997;71:1591-1597.
15. Dal Monte P, Landini MO, Sinclair J, Virelizier JL: TAR and Sp1-independent transactivation of HIV long terminal repeat by the TAT protein in the presence human cytomegalovirus IE1/IE2. AIDS 1997;11:297-303.
16. Contini C, Cultera R, Seraceni S, Segala D, Romani R, Fainardi E, Cinque P, Lazzarin A, Delia S: The role of stage-specific oligonucleotide primers providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS. J Med Microbiol 2002;51:879-890.
17. Gazzinielli RT, Sher A, Cheever A, Gerstberger S, Dickie P: Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo. J Exp Med 1996;183:1645-1655.
18. Orendi JM, Verheul AF, De Vos NM, Visser MR, Snippe H, Cherniak P, Vaishnav VV, Rijkers GT, Verhoef J: Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells and enhance HIV-1 replication. Clin Exp Immunol 1997;107:293-299.